Information Day on Measuring the Impact on Pharmacovigilance Activities
Head of OXON, Dr Nawab Qizilbash will participate in EMA/DIA Information Day on
Measuring the Impact on Pharmacovigilance Activities
EUROPEAN MEDICINES AGENCY | LONDON, UK | 14 NOVEMBER 2017 8:00-16:45 (UK TIME)
Nawab Qizilbash, MD MSc DPhil, Clinical Epidemiologist at OXON (and Joint Coordinator of the ENCePP Special Interest Group on Impact of PV Activities), will speak about "Outcome measures to evaluate the effectiveness of risk minimisation in EU PAS studies: A quantitative review".
The objective of this information day is to take stock of the implementation of the strategy, to discuss enablers and barriers, to impact and to foster collaboration and sharing of information amongst stakeholders.